These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 37014444)

  • 1. Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance.
    Roy PK; Islam J; Lalhlenmawia H
    Egypt Heart J; 2023 Apr; 75(1):24. PubMed ID: 37014444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines mediate inflammation and insulin resistance.
    Kwon H; Pessin JE
    Front Endocrinol (Lausanne); 2013; 4():71. PubMed ID: 23781214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
    Jung UJ; Choi MS
    Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of adipokines.
    Blüher M
    Diabetes Metab J; 2012 Oct; 36(5):317-27. PubMed ID: 23130315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity.
    Frigolet ME; Torres N; Tovar AR
    J Nutr Biochem; 2013 Dec; 24(12):2003-15. PubMed ID: 24120291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing the Adipocytokine NOV: A Novel Approach to Reversing Oxidative Stress-Induced Cardiometabolic Dysfunction.
    Waldman M; Singh SP; Shen HH; Alex R; Rezzani R; Favero G; Hochhauser E; Kornowski R; Arad M; Peterson SJ
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics in the characterization of adipose dysfunction in obesity.
    Brockman D; Chen X
    Adipocyte; 2012 Jan; 1(1):25-37. PubMed ID: 23700508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity.
    El Husseny MW; Mamdouh M; Shaban S; Ibrahim Abushouk A; Zaki MM; Ahmed OM; Abdel-Daim MM
    J Diabetes Res; 2017; 2017():8095926. PubMed ID: 28286779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
    Rajesh Y; Sarkar D
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine functions of adipose tissue.
    Waki H; Tontonoz P
    Annu Rev Pathol; 2007; 2():31-56. PubMed ID: 18039092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of healthy adipose tissue in the treatment of diabetes.
    Gunawardana SC
    World J Diabetes; 2014 Aug; 5(4):420-30. PubMed ID: 25126390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Adipokines in Inflammatory Mechanisms of Obesity.
    Kirichenko TV; Markina YV; Bogatyreva AI; Tolstik TV; Varaeva YR; Starodubova AV
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation-induced microvascular dysfunction in obesity - A translational approach.
    das Graças Coelho de Souza M; Kraemer-Aguiar LG; Bouskela E
    Clin Hemorheol Microcirc; 2016; 64(4):645-654. PubMed ID: 27767971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Adipose Tissue Targets to Prevent and Treat Atherosclerosis.
    Scheja L; Heeren J
    Handb Exp Pharmacol; 2022; 270():289-310. PubMed ID: 33373032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance.
    Al-Mansoori L; Al-Jaber H; Prince MS; Elrayess MA
    Inflammation; 2022 Feb; 45(1):31-44. PubMed ID: 34536157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in the field of obesity and its related comorbidities.
    Katsareli EA; Dedoussis GV
    Expert Opin Ther Targets; 2014 Apr; 18(4):385-401. PubMed ID: 24479492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance.
    Kojta I; Chacińska M; Błachnio-Zabielska A
    Nutrients; 2020 May; 12(5):. PubMed ID: 32375231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between adiponectin, obesity and insulin resistance.
    Balsan GA; Vieira JL; Oliveira AM; Portal VL
    Rev Assoc Med Bras (1992); 2015; 61(1):72-80. PubMed ID: 25909213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should adipokines be considered in the choice of the treatment of obesity-related health problems?
    Athyros VG; Tziomalos K; Karagiannis A; Anagnostis P; Mikhailidis DP
    Curr Drug Targets; 2010 Jan; 11(1):122-35. PubMed ID: 20017725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.